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B-1 and B-2 B cell populations have different progenitors, receptor diversity, anatomic
location, and functions – suggesting vastly differing requisites for homeostatic regulation.
There is evidence that theB lymphocyte stimulator (BLyS) family of cytokines and receptors,
key factors in the homeostatic regulation of B-2 B cell subsets, is also a major player in
the B-1 compartment. Here we review the development and differentiation of these two
primary B cell lineages and their immune functions. We discuss evidence that BLyS or
a proliferation-inducing ligand (APRIL) availability in different anatomic sites, coupled with
signature BLyS receptor expression patterns on different B cell subsets, may be important
for homeostatic regulation of B-1 as well as B-2 populations. Finally, we extend our working
model of B cell homeostasis to integrate B-1s.
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INTRODUCTION
Immunologic activities are frequently categorized as either innate
or adaptive, based largely upon the nature of activating receptors
and subsequent effector activity. Classically, innate immune cells
such as macrophages and dendritic cells use germline encoded
pattern recognition receptors (PRRs) to sense threats. These PRRs
interact with conserved, widely distributed microbial structures
dubbed pathogen associated molecular patterns (PAMPs; Gordon,
2002). Thus, innate responses provide immediate but broadly tar-
geted effector functions, reﬂecting the comparatively limited array
of invariable PRRs. In contrast, the T- andB-lymphocytes involved
in adaptive responses express diverse repertoires of antigen recog-
nition receptors generated through gene rearrangement and point
mutation, yielding more precisely tailored, pathogen-speciﬁc
immune responses.
These broad classiﬁcations, originally stemming from com-
peting theories of immune cognition forwarded by Metchnikoff
and Ehrlich, continue to evolve and remain robust conceptual
constructs. Nonetheless, mounting evidence challenges such sim-
ple binary categorization, suggesting instead that cells of the
mammalian immune system use a continuum of evolutionarily
conserved versus somatically variant receptors, each with distinct
developmental, anatomic, and functional characteristics (Herzen-
berg, 1989; Hirano et al., 2011; Mold and McCune, 2011). Within
the B lymphoid lineage, this view is exempliﬁed by the existence of
two major developmental populations, B-1 and B-2. While both
use somatically generated immunoglobulin (Ig) antigen recog-
nition receptors, they arise from different progenitors, differ in
receptor diversity, occupy distinct anatomic niches, and have
divergent functions.
As detailed below, these differences suggest that B-1 cells
primarily employ an evolutionarily conserved, anticipatory recep-
tor array, are restricted to particular anatomic sites, and target
a limited and relatively constant array of self and microbial
epitopes. Reﬂecting these attributes, appropriate B-1 function
can be accommodated through the establishment of a small,
ﬁxed pool with self-renewal capacity. In contrast, the B-2 pool
is primarily tasked with systemic surveillance for unpredictable
microbial pathogen variants, thus requiring a large pool size and
the continuous turnover of an extensive potential antigen receptor
array. These fundamental distinctions pose vastly different requi-
sites for the homeostatic mechanisms governing pool size and
composition.
The last decade has witnessed a growing appreciation for how
the B lymphocyte stimulator [BLyS, a.k.a. B cell activating factor of
the tumour-necrosis-factor family (BAFF)] family of ligands and
receptors governs selection and homeostasis, particularly among
B-2s and antibody-forming cells (AFCs) derived fromeither B-1 or
B-2 ancestors. These observations prompt the question of whether
this molecular family plays analogous roles in the B-1 lineage,
and how the unique homeostatic demands of the B-1 niche are
accommodated independently of B-2 and AFC niches. Herein we
discuss key features of these twoB cell populations relevant to their
homeostatic requisites, review current knowledge of how the BLyS
family governs homeostasis in the B-2 compartment, and consider
potential BLyS family member roles in the B-1 compartment. We
focus on murine B cell populations, because of the wealth of data
afforded by in vivo experimental systems, but include information
about human B cells as well.
DEVELOPMENT AND RECEPTOR DIVERSITY IN B LINEAGE
POOLS
The B-1 and B-2 cell populations differ in terms of their devel-
opmental kinetics as well as antigen receptor repertoires. Two
hypotheses have been proposed for the development of B-1 versus
B-2 pools. The “separate” lineage model posits distinct, develop-
mentally restricted B-1 and B-2 progenitors, whereas within the
“selection” model the two pools share a common progenitor and
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diverge following ligand-driven selection (reviewed inMontecino-
Rodriguez and Dorshkind, 2006). In mice, B-1 cells are generated
from fetal liver precursors, and proportionally predominate dur-
ing fetal and early neonatal development (Hayakawa et al., 1983;
Carsetti et al., 2004; Montecino-Rodriguez and Dorshkind, 2006;
Montecino-Rodriguez et al., 2006; Yoshimoto et al., 2011). Once
established, B-1 B cells undergo self-renewal in the periphery
(Deenen and Kroese, 1993; Kantor and Herzenberg, 1993; Piatelli
et al., 2003; Ghosn et al., 2011; Yoshimoto et al., 2011). There is
mounting evidence that B-1 cells may continue to be produced
in adult bone marrow (BM), but with greatly reduced frequency
compared to B-2 cell production (Montecino-Rodriguez and Dor-
shkind, 2006, 2011; Montecino-Rodriguez et al., 2006; Yoshimoto
et al., 2011). This early burst of production, followed by self-
renewal and/or an ongoing but low rate of B-1 cell differentiation,
yields a steady-state B-1 cell pool of comparatively small magni-
tude (a few million cells per adult mouse; Hayakawa et al., 1986;
Lalor et al., 1989; Hamilton et al., 1994). Most current models for
peripheral B-1 maturation involve passage through transitional,
intermediate developmental stages followed by differentiation to
B-1a and B-1b subsets in serous cavities (reviewed in Montecino-
Rodriguez and Dorshkind, 2006, 2012; Casola, 2007). In contrast,
B-2 B cells are generated primarily in BM following birth, and
continue to be produced through the lifetime of the individual
(Kantor and Herzenberg, 1993; Carsetti et al., 2004; Ghosn et al.,
2011). Constant B-2 cell production, coupled with a relatively
long average half-life, yields numbers that achieve steady-state at
8 weeks of age, eclipsing the B-1 pool in overall magnitude (tens
of millions of cells per adult mouse; Hayakawa et al., 1983, 1986;
Cancro, 2004a).
Both subsets use recombination activating gene (RAG)-
mediated somatic recombination of Ig gene segments for antigen
receptor expression (Shinkai et al., 1992; Qin et al., 1999). How-
ever, the B-1 lineage differs in two key respects. First, their B
cell receptors (BCRs) tend to be skewed toward using the smaller,
highly conserved J-proximal VH gene segments, such as the
murine VH-11 family (Pennell et al., 1989; Pennell, 1995; Seidl
et al., 1997, 1999; Herzenberg et al., 2000). Second, their fetally
derived progenitors do not engage in N- or P-nucleotide addi-
tions, and thus lack appreciable junctional diversity (Gu et al.,
1990; Kantor et al., 1997; Lipsanen et al., 1997). Moreover, because
they rarely participate in germinal center (GC) reactions engen-
dered by cognate T cell help, their Ig genes rarely undergo somatic
hypermutation and only limited isotype switching (Berland and
Wortis, 2002;Alugupalli et al., 2004; Grifﬁn et al., 2011). As a result,
the array of B-1 receptors is considerably less diverse and, despite
employing somatic recombination per se for their assembly, rep-
resent an essentially germline encoded series of receptors in the
mouse. Paradoxically, the Ig genes of human B-1 cells from cord
blood show few somatic mutations, but have similar N additions
and complementarity determining region 3 (CDR3) lengths when
compared to B-2 cells (Grifﬁn et al., 2011).
In contrast to B-1 cells, developing B-2 cells employ the
entire VH gene cluster at apparently stochastic rates and undergo
extensive junctional diversiﬁcation through N- and P-nucleotide
addition mechanisms (Kantor et al., 1997). Moreover, once recep-
tor expression is achieved following successful IgH and IgL
gene rearrangements, developing B-2 cells undergo stringent
counterselection against cells with autoreactive or signaling-
defective BCRs (Hardy and Hayakawa, 2001). After exiting the
BM and passing through an additional selection checkpoint dur-
ing the transitional developmental stages, newly formed B-2 cells
join the mature, naïve compartments as either follicular (FO) B
cells or splenic marginal zone (MZ) B cells. The vast majority
of these mature B-2 cells are quiescent and thus, unlike the B-1
pool, turnover among B-2 cells is achieved through replacement
by newly formed cells, rather than through self-renewal (Cancro,
2004a; Carsetti et al., 2004).
Clues to understanding the underlying basis for such dif-
ferences in pool size, replacement rates, and receptor diversity
may be found in the distinct roles each pool plays in humoral
immune function (Montecino-Rodriguez and Dorshkind, 2006;
Suzuki et al., 2010). B-1a cells are responsible for so-called nat-
ural antibodies (Abs) – Abs to viral or other pathogen epitopes
that are present before infection/immunization, as well as for
standing IgM and IgA titers to commensal and opportunistic
bacteria (Herzenberg, 2000; Alugupalli and Gerstein, 2005; Baum-
garth et al., 2005; Montecino-Rodriguez and Dorshkind, 2006).
B-1b cells produce Ab upon exposure to pathogens, and confer
some degree of immune memory by continued production of IgM
(Alugupalli et al., 2004; Alugupalli and Gerstein, 2005; Haas et al.,
2005). Natural Abs may recognize self antigens, and thus play a
“housekeeping” role through clearance of senescent cells or cell
debris (Montecino-Rodriguez and Dorshkind, 2006). While B-1
cells can present antigen, B-1 responses do not involve cognate
T help (Martin et al., 2001; Berland and Wortis, 2002; Alugupalli
et al., 2004). B-1 cells constitutively express several molecules that
are only inducibly expressed by splenic B-2s. For example, B-1a
cells have constitutively activated signal transducer and activator
of transcription-3 (STAT3), constitutively phosphorylated extra-
cellular signal-regulated kinase (ERK), and upregulated nuclear
factor of activated T-cells (NF-AT) and transgelin 2 (Karras et al.,
1997). In addition, B-1 cells may be poised to enter cell cycle
(Piatelli et al., 2003). Consistent with observations in mice, human
B-1 cells spontaneously secrete IgM and show tonic intracellular
signaling (Grifﬁn et al., 2011). These observations may begin to
explain why peritoneal B-1 cells can proliferate rapidly, some-
times in the absence of BCR-mediated signaling. B-2 cells, on the
other hand, participate in inducible responses that often involve
T cell help and further receptor diversiﬁcation through somatic
hypermutation of Ig genes within GCs (Chan and Brink, 2012;
Victora and Nussenzweig, 2012). In these structures, successive
mutation and selection processes culminate in B cells with greatly
improved antigen afﬁnity, and class switch recombination leads
to Abs of various isotypes, predominantly IgG (Chan and Brink,
2012; Victora and Nussenzweig, 2012). These cells may further
differentiate and join long-lived antibody-secreting cell (ASC) or
memory B cell subsets (Victora and Nussenzweig, 2012). B-2 B
cells are thus the ultimate “source” of the majority of high-avidity
and high-afﬁnity, pathogen-targeted Abs. MZ B cells, similar to
B-1 cells, have a restricted VH repertoire, are recruited into early
immune responses upon antigen activation, and can rapidly dif-
ferentiate to ASCs without cognate T cell help (Martin et al., 2001;
Martin and Kearney, 2002). MZ B cells may also participate in T
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cell-dependent (TD) GC responses, undergo somatic hypermuta-
tion, and differentiate into memory cells (Song and Cerny, 2003;
Phan et al., 2005).
In accord with their barrier and housekeeping roles, B-1 cells
tend to be localized in particular anatomic niches, especially
coelomic cavities and mucosal interfaces (Kroese et al., 1992), and
though they can circulate, they are rare in spleen and lymph nodes
(Kroese et al., 1992; Montecino-Rodriguez and Dorshkind, 2006).
In contrast, the bulk of B-2 cells (members of the FO subset)
form quiescent recirculating pools, and in any given response, use
only a small (∼1/100,000) proportion of available receptors (Can-
cro et al., 1978). MZ B cells do not recirculate in mice, but their
microanatomical location at the splenic red and white pulp border
makes them the ﬁrst B cells to encounter blood-borne pathogens
(Martin et al., 2001; Belperron et al., 2007; Kearney, 2008).
An exhaustive analysis of B-1a, B-1b, and B-2 cells from the
murine peritoneal cavity indicates that selective pressures in the
periphery, particularly in certain anatomic locales, further shape
the repertoires of all of these B cell subsets (Vale et al., 2010).
For example, cells of all of these subsets that have undergone
N-addition sharemany similarities in repertoire, including enrich-
ment for adult BM CDR3 sequences. This supports both the
hypothesis of different developmental origins as well as a mech-
anism of BCR-inﬂuenced selection as factors that shape B-1 and
B-2 subset repertoires, and make the peritoneal cavity – or other
anatomic locales – more specialized in terms of the antigens recog-
nized and immune responses undertaken (Montecino-Rodriguez
and Dorshkind, 2006, 2012; Vale et al., 2010).
These differences in the generation, repertoire diversiﬁcation,
anatomical location, and immunological function of B-1 and B-
2 populations suggest that cells of the B-1 and B-2 lineages have
very different homeostatic requisites. The smaller, self-renewing
B-1 population, with its relatively limited and static receptor
array, is positioned to make sustained and commonly required
antibody responses – including to evolutionarily “predictable”
microorganisms such as endosymbionts. Continual production
of B-2 cells yields a very large and qualitatively diverse B-2 pop-
ulation well-suited to surveillance and antibody responses against
novel, evolutionarily unpredictable pathogens. The BLyS family of
cytokines and receptors is important for homeostatic regulation
of mature naïve and antigen-experienced B-2 subsets, and there is
evidence that these same molecules also play a role in B-1 home-
ostasis. For the remainder of this review, we discuss a working
model for how the BLyS family may integrate B cell homeostasis
across both primary lineages.
THE BLyS FAMILY PLAYS KEY ROLES IN B-2 B CELL
HOMEOSTASIS AND HUMORAL IMMUNE RESPONSES
The tumor necrosis factor (TNF) superfamily cytokines, BLyS
(also known as BAFF) and a proliferation-inducing ligand
(APRIL), are key regulatory factors in B cell survival and func-
tion (Moore et al., 1999; Schneider et al., 1999; Gross et al., 2001;
Schiemann et al., 2001; Castigli et al., 2004; Belnoue et al., 2008).
BLyS binds to three receptors: BLyS receptor 3 (BR3; also known
as BAFF-R), transmembrane activator-1 and calcium modulator
and cyclophilin ligand-interactor (TACI), and B cell maturation
antigen (BCMA). In contrast, APRIL binds to TACI and BCMA
(Cancro, 2004b; Bossen and Schneider, 2006), and to heparan
sulfate proteoglycans (HSPGs; Hendriks et al., 2005; Ingold et al.,
2005). These relationships are summarized in Figure 1A. Known
or potential roles (indicated by a question mark) of various
receptor-ligand combinations discussed in this review are outlined
in Table 1.
BLyS is the biological metric of space for the pre-immune B-2
cell pool: more BLyS equates with higher absolute numbers of FO
and MZ B cells (Moore et al., 1999; Hsu et al., 2002; Stohl et al.,
2005). BLyS is expressed by monocytes, macrophages, dendritic
cells, and neutrophils, but not by B cells themselves (Moore et al.,
1999; Kawasaki et al., 2002; Litinskiy et al., 2002; Gorelik et al.,
2003; Scapini et al., 2003). However, the major source of systemic
BLyS is likely radiation-resistant stromal cells of secondary lym-
phoid organs; thus linking BLyS amounts to body volume and
consistent with the observation that larger animals have more B
cells than smaller ones (Gorelik et al., 2003). BLyS is a 285-amino
acid type II transmembrane protein, which is cleaved at a furin
consensus site and released as a soluble trimeric ligand (Moore
et al., 1999; Schneider et al., 1999). Both the trimer and a 60-mer
structure (composed of 20 trimers) are detected in serum and
appear to be biologically active. For example, the BLyS trimer
binds with highest afﬁnity to BR3, whereas BLyS 60-mers are the
more efﬁcient TACI agonist (Bossen et al., 2008).
Unlike BLyS, APRIL has no effect on primary B-2 cell numbers
(Castigli et al., 2004; Varfolomeev et al., 2004). This may reﬂect
redundancy with BLyS, and/or roles for APRIL among antigen-
experienced B cell subsets, as discussed further below. APRIL is
expressed by monocytes, dendritic cells, macrophages, T cells,
eosinophils, osteoclasts, and BM stromal cells (Hahne et al., 1998;
Mukhopadhyay et al., 1999; Nardelli et al., 2001; Litinskiy et al.,
2002; Moreaux et al., 2005; Chu et al., 2011). APRIL is a 250-
amino acid type II transmembrane protein processed within the
Golgi apparatus by furin convertase and released as a trimeric bio-
logically active form; it does not form soluble 60-mers like BLyS
(Lopez-Fraga et al.,2001). However, an intergenic splicingbetween
tweak and april genes generates TWE-PRIL protein, which may
exist as a membrane bound form (Pradet-Balade et al., 2002).
Homeostasis of the mature naïve B-2 compartment is governed
by the BLyS–BR3 axis (reviewed in Crowley et al., 2008; Table 1).
BLyS–BR3 signaling integrates BCR-mediated negative selection
at the transitional developmental checkpoint with homeostasis of
the mature naïve compartment. BLyS is a limiting survival fac-
tor, and only those cells that successfully compete for it persist
in the FO or MZ B cell pools. If BLyS levels are reduced or BR3
signaling is abrogated, fewer cells survive the transitional check-
point, and numbers of FO and MZ B cells are reduced or, in
the case of BLyS knockouts, virtually non-existent (Miller and
Hayes, 1991; Lentz et al., 1996; Gross et al., 2001; Schiemann et al.,
2001; Thompson et al., 2001; Yan et al., 2001). Conversely, if BLyS
levels are experimentally elevated, the stringency of transitional
selection is “relaxed,” and cells that would normally be selected
against – such as those with autoreactive BCRs – instead survive
to join the FO or MZ pool (Stohl, 2005; Stohl et al., 2005). Num-
bers of cells in each of these subsets are correspondingly increased
(Hsu et al., 2002). Thus, the BLyS–BR3 axis also plays a key role in
peripheral tolerance (Stohl, 2005; Stohl et al., 2005). The number
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FIGURE 1 | BLyS family members (except for HSPG) and model for BLyS
family roles in B cell homeostasis. (A) BLyS binds to all three receptors –
BR3 (circle), TACI (rectangle), and BCMA (triangle) – with relative afﬁnity
indicated by line thickness. APRIL binds only to TACI and BCMA, but also to
HSPGs expressed on B cells. (B) Diagrammatic representation of potential
homeostatic niches, governed in part by BLyS or APRIL signaling through
speciﬁc BLyS receptor(s). Persistence of naïve follicular (FO) and marginal
zone (MZ) B cells is governed by BLyS signaling through BR3, yet cells of
these subsets also expressTACI, and there is evidence that APRIL signaling
throughTACI is key for isotype switching to IgA following antigen encounter.
BCMA is required for long-lived plasma cell (PC) maintenance in bone marrow
(BM) likely by APRIL signaling through this receptor, but BLyS may also play a
role. B-1 B cell maintenance may require BLyS in the spleen but APRIL in the
peritoneal cavity.
of B cells reaches several million (MZ) or tens of millions (FO) in
the adult mouse. These cells are quiescent and reside in the com-
partment for the duration of their lifespan (measured in months)
unless they respond to antigen. Thus, the developing B-2 lineage
yields a mature naïve compartment of sufﬁcient steady-state size
and diversity for effective immune surveillance, along with sufﬁ-
cient quality to avoid autoreactivity. Mounting evidence indicates
that the BLyS–BR3 axis governs primary B cell homeostasis in
humans as well: naïve mature human B cells express BR3 and bind
BLyS; people with a homozygous BR3 deletion have few mature B
cells; and mature naïve B cells are ablated with anti-BLyS therapy
(belimumab; Carter et al., 2005; Darce et al., 2007a,b; Palanichamy
et al., 2009; Warnatz et al., 2009; Calero et al., 2010).
Members of the BLyS family also play roles in humoral immune
responses undertaken by B-2 B cells in both mice and humans.
BLyS is essential for humoral immune responses in mice, as
blocking BLyS signaling leads to signiﬁcantly impaired TD and T
cell-independent (TI) immune responses (Gross et al., 2001; Schie-
mann et al., 2001; Vora et al., 2003; Scholz et al., 2008). APRIL
is also suggested to have roles in immune responses. For exam-
ple,APRIL transgenics show signiﬁcantly elevated antigen-speciﬁc
IgM and IgG in response to a TI type 2 antigen (Stein et al.,
2002), and APRIL plays a key role in IgA class switch and the
IgA antibody response to mucosal and TI type 1 antigens (Castigli
et al., 2004). Knockout mice show TACI is the BLyS family recep-
tor important for APRIL-mediated IgA class switching (Castigli
et al., 2004; Sakurai et al., 2007), though other work shows that
the BLyS–TACI interaction also mediates isotype switch (Castigli
et al., 2005). In vitro studies indicate that APRIL synergizes with
BCR cross-linking to induce B cell proliferation, and also induces
the upregulation of co-stimulatory molecules and the antigen pre-
sentation function of B cells (Yu et al., 2000; Yang et al., 2005).
Either BLyS or APRIL (with other appropriate cytokines) elicits
TI-like class switching in cultured human B cells (Litinskiy et al.,
2002). Interestingly, a range of mutations in TACI is associated
with common variable immune deﬁciency (CVID) and IgA deﬁ-
ciency (Castigli et al., 2007; Lobito et al., 2011; Martinez-Gallo
et al., 2013). Furthermore, there is increasing evidence in both
mice and humans that TI responses to many innate-like antigens
occur through pathways that integrate BLyS or APRIL signaling
through TACI with Toll-like receptor (TLR) signaling (He et al.,
2010; Oropallo et al., 2011).
Heparan sulfate proteoglycans have been identiﬁed as an
APRIL-speciﬁc binding receptor on both B-1 and B-2 cells (Hen-
driks et al., 2005; Ingold et al., 2005). APRIL contains a short, basic
amino acid sequence that is absent in BLyS; in association with
additional basic residues these are required for APRIL binding to
negatively chargedHSPGs. Crystal structures reveal that theHSPG
binding site of APRIL is clearly distinct from that of TACI and
BCMA; and APRIL binding to HSPG is not inhibited by BCMA:Fc
(Wallweber et al., 2004; Hendriks et al., 2005; Ingold et al., 2005).
HSPG-mediated binding of APRIL is essential for B cell prolif-
eration and IgA production in collaboration with TACI (Sakurai
et al., 2007), raising the possibility of ternary complex formation
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Table 1 | Roles for cytokine-receptor signals in murine B cell homeostasis.
BLyS APRIL
BR3 • Transitional selection
(Hsu et al., 2002; Crowley et al., 2008; Stohl et al., 2011)
• FO, MZ survival
(Lentz et al., 1996; Gross et al., 2001; Hsu et al., 2002)
• GC evolution
(Schiemann et al., 2001; Rahman et al., 2003; Vora et al., 2003)
• TLR/BCR crosstalk, regulation?
(He et al., 2010; Oropallo et al., 2011)
• B-1 maintenance in spleen?
(Lentz et al., 1996; Ng et al., 2006; Scholz et al., 2008; Mackay et al., 2010)
TACI • Class switch
(Litinskiy et al., 2002; Castigli et al., 2005)
• B-1 maintenance in spleen?
(Lentz et al., 1996; Ng et al., 2006; Scholz et al., 2008; Mackay et al., 2010)
• Integration of TLR signals?
(Litinskiy et al., 2002; He et al., 2010; Oropallo et al., 2011)
• IgA class switch, B-2 and B-1 cells
(Litinskiy et al., 2002; Stein et al., 2002; Castigli et al., 2004;
Sakurai et al., 2007; Kataoka et al., 2011)
• Short-lived ASC responses
(Castigli et al., 2005; Yang et al., 2005)
• B-1 maintenance in the peritoneum?
(Gross et al., 2001; Shulga-Morskaya et al., 2004)
• APRIL-HSPG-TACI signaling?
(Sakurai et al., 2007; Kimberley et al., 2009)
BCMA • Long-lived plasma cell generation and/or maintenance
(O’Connor et al., 2004; Ingold et al., 2005; Benson et al., 2008)
• Memory B cell recall response?
(Avery et al., 2003; Darce et al., 2007a,b; Ettinger et al., 2007;
Scholz et al., 2008)
• Long-lived plasma cell homing to or maintenance in BM
(O’Connor et al., 2004; Belnoue et al., 2008; Benson et al., 2008)
HSPG • B cell maturation
(Reijmers et al., 2011)
• IgA class switch
(Sakurai et al., 2007)
• Plasma cell survival
(Reijmers et al., 2011)
• B-1 maintenance in the peritoneum?
(Gross et al., 2001; Shulga-Morskaya et al., 2004)
of APRIL–TACI–HSPG. In this regard, a study by Kimberley et al.
(2009) showed that HSPG serves as a platform for APRIL mul-
timerization on the cell surface, which can then signal through
TACI for optimal activation of B cells.
Germinal centers, a hallmark of TD immune responses, gen-
erate high-afﬁnity, class-switched antibody as well as persistent
(long-lived) plasma cells andmemory B cells (Victora andNussen-
zweig, 2012). GCs begin in the absence of BLyS or BR3, but are not
maintained – likely reﬂecting the paucity of naïve B cells available
for recruitment into the ongoing GC reaction, but also suggesting
a role for BLyS–BR3 signaling in GC evolution (Rahman et al.,
2003; Vora et al., 2003). Likewise, high-afﬁnity, class-switched
antibody responses are signiﬁcantly reduced, and the memory
response is impaired (Schiemann et al., 2001). Studies of APRIL
knockouts indifferent genetic backgrounds report disparate effects
upon TD antigen challenge: either a normal humoral response,
or enlarged GCs and an enhanced IgG response (Castigli et al.,
2004; Varfolomeev et al., 2004). There is increasing evidence that
both BLyS and APRIL are required for plasma cell generation and
maintenance (Ingold et al., 2005; Benson et al., 2008), and that
APRIL is important for plasma cell homing to or retention in the
BM (Ingold et al., 2005; Belnoue et al., 2008). Studies of BCMA
knockouts show that this receptor is critical for maintenance of
long-lived plasma cells in BM (O’Connor et al., 2004). In addition,
HSPGs are key for APRIL-mediated plasma cell survival (Reijmers
et al., 2011).
Memory B cells appear to occupy a BLyS-independent home-
ostatic niche in mice. Neither BLyS nor APRIL is required for
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memory B cell maintenance in mice treated with anti-BLyS,
BR3-Ig, or TACI-Ig, though unswitched (IgM) memory cells are
less resistant to BLyS neutralization (Benson et al., 2008; Scholz
et al., 2008). In contrast, BLyS promotes survival of resting human
memory B cells and plasmablasts (Avery et al., 2003; Ettinger et al.,
2007; Karnell andEttinger, 2012). BLyS treatment of humanmem-
ory B cells (CD27+) in vitro attenuatesASC formationwith TI-like
stimulation but enhancesASC formationwithTD-like stimulation
(Darce et al., 2007a), and activated cells upregulate BCMA (Darce
et al., 2007b), again pointing to roles for BLyS family members in
human plasma cell differentiation. BCMAand/or TACI expression
have been reported on murine and human memory B cells, but
elucidation of expression levels and patterns – as well as homeo-
static requisites – awaits deﬁnitive characterization of memory B
cell subsets (Darce et al., 2007b; Benson et al., 2008; Tomayko et al.,
2010; Scholz et al., 2011).
BLyS FAMILY MEMBERS MAY PLAY ROLES IN B-1 B CELL
HOMEOSTASIS
The molecules that govern generation, maintenance, and selec-
tion of B-1 subsets are under active investigation. However, there
is increasing evidence that BLyS family members play analogous
but distinct roles in B-1 and B-2 pools. Peritoneal B-1 cells
of mice express both BR3 and TACI, but barely detectable sur-
face BCMA (Ng et al., 2006). Nevertheless, BR3 knockouts, BR3
signaling-mutant mice, and BLyS knockouts all have wild-type
or moderately (not signiﬁcantly) reduced numbers of B-1 cells
in the peritoneal cavity (Lentz et al., 1996; Schneider et al., 2001;
Sasaki et al., 2004; Shulga-Morskaya et al., 2004; Gavin et al., 2005).
BLyS-overexpressing mice show a signiﬁcant increase in splenic B-
1 numbers and peritoneal cavity B-1 percentages (Gavin et al.,
2005), consistent with some prior reports (Gross et al., 2001),
but not others indicating similarity between B-1 populations in
BLyS transgenic andwild-typemice (Mackay et al., 1999). Interest-
ingly, mice in which BLyS was neutralized had reduced splenic B-1
numbers but normal peritoneal B-1 numbers (Scholz et al., 2008),
suggesting the possibility of different homeostatic requisites in dif-
ferent anatomic environments. There was a signiﬁcant decrease in
peritoneal B-1 numbers inmice transgenic for TACI-Ig, amolecule
that neutralizes both BLyS and APRIL (Gross et al., 2001). In con-
trast, TACI-Fc transgenic mice showed only a negligible decrease
in peritoneal B-1 subsets (Schneider et al., 2001). B-1 transitional
cells are not dependent on BR3 signaling, although similar to B-
2 transitional cells, BCR signaling is required for survival and
continued maturation (Mackay et al., 2010; Montecino-Rodriguez
and Dorshkind, 2011). BLyS treatment of B-1 cells stimulated
with TLR ligands leads to upregulated BR3 and TACI expression,
increased proliferation, and cytokine secretion (Ng et al., 2006).
Together these results suggest that neither BR3 nor BLyS is abso-
lutely necessary for B-1 cell development, selection, or survival in
the periphery, though BLyS may modulate B-1 cell maintenance or
responses in certain anatomic sites, for example through localized
BLyS production by myeloid cells (Gavin et al., 2005; Table 1).
Clearly, peritoneal B-1 cells are far less dependent on BLyS
than are B-2 cells. One possible explanation is that peritoneal B-1
cells require alternative or redundant survival factors, for exam-
ple, APRIL (discussed further below). Unlike splenic B-2 cells,
peritoneal B-1 cells are constitutively active with regard to surface
and intracellular activation markers and spontaneous IgM secre-
tion (Fischer et al., 2001; Kretschmer et al., 2003; Tumang et al.,
2004); and activated B cells may have different survival requisites
than quiescent cells. Splenic and peritoneal B-1a cells both express
CD5, but only peritoneal B-1 cells respond to PMA as shown
by cell cycle progression, Ig secretion, and expression of Notch-
related genes (Fischer et al., 2001; Tumang et al., 2004). As noted
above, peritoneal but not splenic B-1 cells express a constitutively
activated form of STAT3, which regulates IL-10 gene expression
(Fischer et al., 2001). In addition, the microenvironment of the
peritoneal cavity is thought to be very different from that of the
spleen, and may contain redundant or alternative survival factors
that can substitute for BLyS. Therefore, it is tempting to speculate
that splenic and peritoneal B-1 cells are homeostatically differ-
ent from each other as well as from B-2 subsets and may require
different signal/s for survival.
Likewise, there is evidence, albeit indirect and in some cases
conﬂicting, that APRIL may play roles in B-1 B cell main-
tenance or responses. Indeed, B-1 B cells express BR3 and
TACI (Ng et al., 2006), and in one report, peritoneal B-1 cells
expressed a higher level of TACI compared with peritoneal B-
2 cells (similar to the higher level of TACI expressed by MZ B
cells compared to FO B cells; Shulga-Morskaya et al., 2004; Ng
et al., 2006; Stadanlick et al., 2008). Nonetheless, TACI knockout
mice have normal numbers of peritoneal B-1 cells (von Bulow
et al., 2001). APRIL knockout mice were reported to have nor-
mal percentages of peritoneal B-1 cells (Castigli et al., 2004), yet
APRIL transgenic mice had increased percentages of splenic B-
1 cells (Planelles et al., 2004). APRIL knockout mice also have
signiﬁcantly decreased serum IgA levels as well as IgA responses
to orally administered antigen (Castigli et al., 2004); however,
although IgA is an isotype normally associated with B-1 cells,
it is not known if B-2 as well as B-1 cells were involved in
these responses. There are conﬂicting reports of B-1 cell preva-
lence in mice that should have been chronically depleted of
both BLyS and APRIL using soluble receptor transgenes (Gross
et al., 2001; Schneider et al., 2001). The discrepancy in these
observations may have been due to differences in the trans-
genes and expression cassettes employed; or to insufﬁcient levels
of soluble receptor for complete neutralization of both BLyS
(including BLyS 60-mers) and APRIL. Ex vivo observations and
cell culture experiments indicate that mucosal dendritic cells
upregulate APRIL production, and B-1a cells upregulate TACI
and undergo enhanced class switching to IgA in a mucosal, TI
immune response (Kataoka et al., 2011), echoing roles for APRIL
and TACI in TI responses of B-2 B cells. Taken together, these
observations suggest potential roles for APRIL in B-1 cell sur-
vival, activation, or function, but comprehensive analyses will
be required to clarify the mechanisms involved. There are sev-
eral approaches that might be taken to deﬁnitively establish the
role of APRIL in B-1 cell origin/maintenance, such as detailed
studies of B-1 cell numbers in APRIL knockout mice, or enu-
meration of B-1 cells in BCMA:Fc transgenic mice or following
BCMA:Fc treatment of wild-type mice. Furthermore, it will be
important to examine the role of the APRIL–HSPG axis, since
B-1 cells express TACI, and HSPGs can serve as a platform for
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APRIL multimerization and cross-linking with TACI (Kimberley
et al., 2009).
SUMMARY
The two major B lymphocyte lineages, B-1 and B-2, together
provide an array of antigen recognition receptors for “expected”
endogenous antigens as well as “unexpected” novel/exogenous
antigens; patrolling (circulating) as well as location-speciﬁc
surveillance and persistence; constitutive as well as inducible Ab
production; and rapid as well as longer-term humoral responses.
BLyS family molecules play key roles in the maturation and
maintenance of B-2 B cell subsets in the periphery, and there is
increasing evidence that this same family plays similar roles for
cells of the B-1 lineage. Therefore, we now include B-1 cells in
our working model for BLyS-mediated homeostatic control, out-
lined in Figure 1B (Crowley et al., 2005, 2008; Miller et al., 2006;
Treml et al., 2006, 2009). B-1 cells are placed in the area of over-
lap between the “BLyS space” and the “APRIL space” based on
mounting evidence that BLyS and/or APRIL modulate B-1 cell
maintenance or responses in different anatomic locales. For exam-
ple, a role for APRIL in B-1 survival is suggested by one report
of a nearly complete absence of peritoneal B-1 cells in TACI-Ig
transgenic mice, compared with the smaller or localized effects
on peritoneal B-1 numbers and lifespan in BLyS-deﬁcient, BLyS-
neutralized, or BR3 signaling-deﬁcient animals; whereas more
nuanced roles are indicated for BLyS and B-1 cell survival or func-
tion in the spleen. APRIL is further implicated by the expression
of HSPG on peritoneal B-1 cells.
This model for regulation of steady-state numbers of various
B cell subsets is based on BLyS or APRIL availability and BLyS
receptor expression patterns. For example, ample experimen-
tal evidence shows that systemic, trimeric BLyS acting through
BR3 regulates selection thresholds and lifespan in the periph-
ery, thus achieving steady-state numbers of mature naïve FO
and MZ B cells. Differential expression of BLyS receptors dur-
ing activation and further differentiation to ASC or memory B
cells provides related, yet distinct, homeostatic niches. Local-
ized cytokine sources may afford survival requisites, as has been
suggested for the persistence of long-lived plasma cells in BM
and for the maintenance or expansion of B-1 cells (Gavin et al.,
2005; Chu et al., 2011). Indeed, existing evidence suggests that
whereas BLyS is key for naïve B-2 cells, APRIL is important dur-
ing or following differentiation to ASCs (Figure 1B). Additional
molecules yet to be identiﬁed are likely involved in establishment
and maintenance of antigen-experienced B cell subsets, possi-
bly molecules whose expression is restricted to speciﬁc anatomic
milieus, including long-lived plasma cells,memory B cells, andB-1
cells. Nevertheless, it is becoming increasingly clear that the BLyS
family may elegantly integrate homeostasis of both B-1 and B-2
lineages.
REFERENCES
Alugupalli, K. R., and Gerstein, R. M.
(2005). Divide and conquer: division
of labor by B-1 B cells. Immunity 23,
1–2.
Alugupalli, K. R., Leong, J. M., Wood-
land,R.T.,Muramatsu,M.,Honjo,T.,
and Gerstein, R. M. (2004). B1b lym-
phocytes confer T cell-independent
long-lasting immunity. Immunity 21,
379–390.
Avery, D. T., Kalled, S. L., Ellyard, J.
I., Ambrose, C., Bixler, S. A., Thien,
M., et al. (2003). BAFF selectively
enhances the survival of plasmablasts
generated from human memory B
cells. J. Clin. Invest. 112, 286–297.
Baumgarth, N., Tung, J. W., and
Herzenberg, L. A. (2005). Inher-
ent speciﬁcities in natural antibodies:
a key to immune defense against
pathogen invasion. Springer Semin.
Immunopathol. 26, 347–362.
Belnoue, E., Pihlgren, M., McGaha, T.
L., Tougne, C., Rochat, A. F., Bossen,
C., et al. (2008). APRIL is critical for
plasmablast survival in the bone mar-
row andpoorly expressed by early-life
bone marrow stromal cells. Blood
111, 2755–2764.
Belperron, A. A., Dailey, C. M.,
Booth, C. J., and Bockenstedt, L. K.
(2007). Marginal zone B-cell deple-
tion impairs murine host defense
against Borrelia burgdorferi infec-
tion. Infect. Immun. 75, 3354–
3360.
Benson, M. J., Dillon, S. R., Castigli, E.,
Geha, R. S., Xu, S., Lam, K. P., et al.
(2008). Cutting edge: the dependence
of plasma cells and independence of
memory B cells on BAFF and APRIL.
J. Immunol. 180, 3655–3659.
Berland, R., and Wortis, H. H. (2002).
Origins and functions of B-1 cells
with notes on the role of CD5. Annu.
Rev. Immunol. 20, 253–300.
Bossen, C., Cachero, T. G., Tardivel,
A., Ingold, K., Willen, L., Dobles,
M., et al. (2008). TACI, unlike BAFF-
R, is solely activated by oligomeric
BAFF and APRIL to support survival
of activated B cells and plasmablasts.
Blood 111, 1004–1012.
Bossen, C., and Schneider, P. (2006).
BAFF, APRIL and their receptors:
structure, function and signaling.
Semin. Immunol. 18, 263–275.
Calero, I., Nieto, J. A., and Sanz, I.
(2010). B cell therapies for rheuma-
toid arthritis: beyondB cell depletion.
Rheum. Dis. Clin. North Am. 36,
325–343.
Cancro, M. P. (2004a). Peripheral B-cell
maturation: the intersection of selec-
tion and homeostasis. Immunol. Rev.
197, 89–101.
Cancro, M. P. (2004b). The BLyS family
of ligands and receptors: an archetype
for niche-speciﬁc homeostatic regu-
lation. Immunol. Rev. 202, 237–249.
Cancro, M. P., Gerhard, W., and Klin-
man, N. R. (1978). The diversity of
the inﬂuenza-speciﬁc primary B-cell
repertoire in BALB/c mice. J. Exp.
Med. 147, 776–787.
Carsetti, R., Rosado, M. M., and Ward-
mann, H. (2004). Peripheral devel-
opment of B cells in mouse and man.
Immunol. Rev. 197, 179–191.
Carter, R. H., Zhao, H., Liu, X., Pelletier,
M., Chatham, W., Kimberly, R., et al.
(2005). Expression and occupancy of
BAFF-R on B cells in systemic lupus
erythematosus. Arthritis Rheum. 52,
3943–3954.
Casola, S. (2007). Control of periph-
eral B-cell development. Curr. Opin.
Immunol. 19, 143–149.
Castigli, E., Scott, S., Dedeoglu, F.,
Bryce, P., Jabara, H., Bhan,A. K., et al.
(2004). Impaired IgA class switching
in APRIL-deﬁcient mice. Proc. Natl.
Acad. Sci. U.S.A. 101, 3903–3908.
Castigli, E., Wilson, S. A., Elkhal,
A., Ozcan, E., Garibyan, L.,
and Geha, R. S. (2007). Trans-
membrane activator and calcium
modulator and cyclophilin ligand
interactor enhances CD40-driven
plasma cell differentiation. J. Allergy
Clin. Immunol. 120, 885–891.
Castigli, E., Wilson, S. A., Scott, S.,
Dedeoglu, F., Xu, S., Lam, K. P., et al.
(2005). TACI and BAFF-R mediate
isotype switching in B cells. J. Exp.
Med. 201, 35–39.
Chan, T. D., and Brink, R. (2012).
Afﬁnity-based selection and the ger-
minal center response. Immunol. Rev.
247, 11–23.
Chu, V. T., Frohlich, A., Steinhauser, G.,
Scheel, T., Roch,T., Fillatreau, S., et al.
(2011). Eosinophils are required for
the maintenance of plasma cells in
the bone marrow. Nat. Immunol. 12,
151–159.
Crowley, J. E., Scholz, J. L., Quinn,
W. J. III, Stadanlick, J. E., Treml,
J. F., Treml, L. S., et al. (2008).
Homeostatic control of B lymphocyte
subsets. Immunol. Res. 42, 75–83.
Crowley, J. E., Treml, L. S., Stadanlick,
J. E., Carpenter, E., and Cancro, M.
P. (2005). Homeostatic niche speci-
ﬁcation among naive and activated B
cells: a growing role for the BLyS fam-
ily of receptors and ligands. Semin.
Immunol. 17, 193–199.
Darce, J. R., Arendt, B. K., Chang, S. K.,
and Jelinek, D. F. (2007a). Divergent
effects of BAFF on human memory
B cell differentiation into Ig-secreting
cells. J. Immunol. 178, 5612–5622.
Darce, J. R., Arendt, B. K., Wu, X.,
and Jelinek, D. F. (2007b). Regulated
expression of BAFF-binding recep-
tors during human B cell differenti-
ation. J. Immunol. 179, 7276–7286.
Deenen, G. J., and Kroese, F. G. (1993).
Kinetics of peritoneal B-1a cells (CD5
B cells) in young adult mice. Eur. J.
Immunol. 23, 12–16.
Ettinger, R., Sims, G. P., Robbins, R.,
Withers, D., Fischer, R. T., Gram-
mer, A. C., et al. (2007). IL-21 and
BAFF/BLyS synergize in stimulating
plasma cell differentiation from a
www.frontiersin.org February 2013 | Volume 4 | Article 37 | 7
“ﬁmmu-04-00037” — 2013/2/22 — 15:35 — page 8 — #8
Sindhava et al. Homeostasis of innate/adaptive B cells
unique population of human splenic
memory B cells. J. Immunol. 178,
2872–2882.
Fischer, G. M., Solt, L. A., Hastings, W.
D., Yang, K., Gerstein, R. M., Nikola-
jczyk, B. S., et al. (2001). Splenic and
peritoneal B-1 cells differ in terms
of transcriptional and proliferative
features that separate peritoneal B-1
from splenic B-2 cells. Cell. Immunol.
213, 62–71.
Gavin, A. L., Duong, B., Skog, P., Ait-
Azzouzene, D., Greaves, D. R., Scott,
M. L., et al. (2005). delta BANFF, a
splice isoform of BAFF, opposes full-
length BAFF activity in vivo in trans-
genicmousemodels. J. Immunol. 175,
319–328.
Ghosn, E. E., Sadate-Ngatchou, P., Yang,
Y., and Herzenberg, L. A. (2011). Dis-
tinct progenitors for B-1 and B-2 cells
are present in adult mouse spleen.
Proc. Natl. Acad. Sci. U.S.A. 108,
2879–2884.
Gordon, S. (2002). Pattern recognition
receptors: doubling up for the innate
immune response. Cell 111, 927–930.
Gorelik, L., Gilbride, K., Dobles, M.,
Kalled, S. L., Zandman, D., and Scott,
M. L. (2003). Normal B cell home-
ostasis requires B cell activation fac-
tor production by radiation-resistant
cells. J. Exp. Med. 198, 937–945.
Grifﬁn, D. O., Holodick, N. E., and
Rothstein, T. L. (2011). Human B1
cells in umbilical cord and adult
peripheral blood express the novel
phenotype CD20+ CD27+ CD43+
CD70−. J. Exp. Med. 208, 67–80.
Gross, J. A., Dillon, S. R., Mudri,
S., Johnston, J., Littau, A., Roque,
R., et al. (2001). TACI-Ig neutral-
izes molecules critical for B cell
development and autoimmune dis-
ease. impaired B cell maturation
in mice lacking BLyS. Immunity 15,
289–302.
Gu, H., Forster, I., and Rajewsky,
K. (1990). Sequence homologies, N
sequence insertion and JH gene uti-
lization in VHDJH joining: implica-
tions for the joining mechanism and
the ontogenetic timing of Ly1 B cell
and B-CLL progenitor generation.
EMBO J. 9, 2133–2140.
Haas, K. M., Poe, J. C., Steeber, D. A.,
and Tedder, T. F. (2005). B-1a and B-
1b cells exhibit distinct developmen-
tal requirements and have unique
functional roles in innate and adap-
tive immunity to S. pneumoniae.
Immunity 23, 7–18.
Hahne, M., Kataoka, T., Schroter, M.,
Hofmann, K., Irmler, M., Bodmer, J.
L., et al. (1998). APRIL, a new ligand
of the tumor necrosis factor family,
stimulates tumor cell growth. J. Exp.
Med. 188, 1185–1190.
Hamilton, A. M., Lehuen, A., and Kear-
ney, J. F. (1994). Immunoﬂuores-
cence analysis of B-1 cell ontogeny in
the mouse. Int. Immunol. 6, 355–361.
Hardy, R. R., and Hayakawa, K. (2001).
B cell development pathways. Annu.
Rev. Immunol. 19, 595–621.
Hayakawa,K.,Hardy,R. R., andHerzen-
berg, L. A. (1986). Peritoneal Ly-1 B
cells: genetic control, autoantibody
production, increased lambda light
chain expression. Eur. J. Immunol. 16,
450–456.
Hayakawa, K., Hardy, R. R., Parks, D.
R., and Herzenberg, L. A. (1983). The
“Ly-1B”cell subpopulation innormal
immunodefective, and autoimmune
mice. J. Exp. Med. 157, 202–218.
He, B., Santamaria, R., Xu, W., Cols, M.,
Chen, K., Puga, I., et al. (2010). The
transmembrane activator TACI trig-
gers immunoglobulin class switch-
ing by activating B cells through the
adaptor MyD88. Nat. Immunol. 11,
836–845.
Hendriks, J., Planelles, L., de Jong-
Odding, J., Hardenberg, G., Pals,
S. T., Hahne, M., et al. (2005).
Heparan sulfate proteoglycan bind-
ing promotes APRIL-induced tumor
cell proliferation. Cell Death Differ.
12, 637–648.
Herzenberg, L. A. (1989). Toward a
layered immune system. Cell 59,
953–954.
Herzenberg, L. A. (2000). B-1 cells: the
lineage question revisited. Immunol.
Rev. 175, 9–22.
Herzenberg, L. A., Baumgarth, N., and
Wilshire, J. A. (2000). B-1 cell ori-
gins and VH repertoire determina-
tion. Curr. Top. Microbiol. Immunol.
252, 3–13.
Hirano,M.,Das, S.,Guo, P., andCooper,
M. D. (2011). The evolution of adap-
tive immunity in vertebrates. Adv.
Immunol. 109, 125–157.
Hsu, B. L., Harless, S. M., Lindsley,
R. C., Hilbert, D. M., and Can-
cro, M. P. (2002). Cutting edge:
BLyS enables survival of transitional
and mature B cells through distinct
mediators. J. Immunol. 168, 5993–
5996.
Ingold, K., Zumsteg, A., Tardivel, A.,
Huard, B., Steiner, Q. G., Cachero,
T. G., et al. (2005). Identiﬁcation of
proteoglycans as the APRIL-speciﬁc
binding partners. J. Exp. Med. 201,
1375–1383.
Kantor, A. B., and Herzenberg, L.
A. (1993). Origin of murine B cell
lineages. Annu. Rev. Immunol. 11,
501–538.
Kantor, A. B., Merrill, C. E., Herzen-
berg, L. A., and Hillson, J. L. (1997).
An unbiased analysis of V(H)-D-
J(H) sequences from B-1a, B-1b, and
conventional B cells. J. Immunol. 158,
1175–1186.
Karnell, J. L., and Ettinger, R.
(2012). The interplay of IL-21 and
BAFF in the formation and main-
tenance of human B cell mem-
ory. Front. Immunol. 3:2. doi:
10.3389/ﬁmmu.2012.00002
Karras, J. G.,Wang, Z.,Huo, L.,Howard,
R. G., Frank, D. A., and Rothstein,
T. L. (1997). Signal transducer and
activator of transcription-3 (STAT3)
is constitutively activated in nor-
mal, self-renewing B-1 cells but only
inducibly expressed in conventional
B lymphocytes. J. Exp. Med. 185,
1035–1042.
Kataoka, K., Fujihashi, K., Terao,
Y., Gilbert, R. S., Sekine, S.,
Kobayashi, R., et al. (2011). Oral-
nasopharyngeal dendritic cells medi-
ate T cell-independent IgA class
switching on B-1 B cells. PLoS
ONE 6:e25396. doi: 10.1371/jour-
nal.pone.0025396
Kawasaki, A., Tsuchiya, N., Fukazawa,
T., Hashimoto, H., and Toku-
naga, K. (2002). Analysis on the
association of human BLYS (BAFF,
TNFSF13B) polymorphisms with
systemic lupus erythematosus and
rheumatoid arthritis. Genes Immun.
3, 424–429.
Kearney, J. F. (2008). B cell subpopula-
tions and secondary lymphoid organ
architecture. Semin. Immunol. 20,
1–3.
Kimberley, F. C., van Bostelen, L.,
Cameron, K., Hardenberg, G., Mar-
quart, J. A., Hahne, M., et al. (2009).
The proteoglycan (heparan sulfate
proteoglycan) binding domain of
APRIL serves as a platform for ligand
multimerization and cross-linking.
FASEB J. 23, 1584–1595.
Kretschmer, K., Jungebloud, A., Stop-
kowicz, J., Stoermann, B., Hoffmann,
R., and Weiss, S. (2003). Antibody
repertoire and gene expression pro-
ﬁle: implications for different devel-
opmental and functional traits of
splenic and peritoneal B-1 lympho-
cytes. J. Immunol. 171, 1192–1201.
Kroese, F. G., Ammerlaan, W. A., and
Deenen, G. J. (1992). Location and
function of B-cell lineages. Ann. N. Y.
Acad. Sci. 651, 44–58.
Lalor, P. A., Herzenberg, L. A., Adams,
S., and Stall, A. M. (1989). Feed-
back regulation of murine Ly-1 B cell
development. Eur. J. Immunol. 19,
507–513.
Lentz, V. M., Cancro, M. P., Nashold, F.
E., and Hayes, C. E. (1996). Bcmd
governs recruitment of new B cells
into the stable peripheral B cell pool
in the A/WySnJ mouse. J. Immunol.
157, 598–606.
Lipsanen, V., Walter, B., Emara, M.,
Siminovitch,K., Lam, J., andKaushik,
A. (1997). Restricted CDR3 length of
the heavy chain is characteristic of six
randomly isolated disease-associated
VH J558+ IgM autoantibodies in
lupus prone moth-eaten mice. Int.
Immunol. 9, 655–664.
Litinskiy, M. B., Nardelli, B., Hilbert,
D. M., He, B., Schaffer, A., Casali,
P., et al. (2002). DCs induce CD40-
independent immunoglobulin class
switching through BLyS and APRIL.
Nat. Immunol. 3, 822–829.
Lobito, A. A., Gabriel, T. L., Medema, J.
P., and Kimberley, F. C. (2011). Dis-
ease causing mutations in the TNF
and TNFR superfamilies: focus on
molecular mechanisms driving dis-
ease. Trends Mol. Med. 17, 494–505.
Lopez-Fraga, M., Fernandez, R., Albar,
J. P., and Hahne, M. (2001). Bio-
logically active APRIL is secreted fol-
lowing intracellular processing in the
Golgi apparatus by furin convertase.
EMBO Rep. 2, 945–951.
Mackay, F., Figgett, W. A., Saulep,
D., Lepage, M., and Hibbs, M. L.
(2010). B-cell stage and context-
dependent requirements for sur-
vival signals from BAFF and the
B-cell receptor. Immunol. Rev. 237,
205–225.
Mackay, F., Woodcock, S. A., Law-
ton, P., Ambrose, C., Baetscher, M.,
Schneider, P., et al. (1999). Mice
transgenic for BAFFdevelop lympho-
cytic disorders along with autoim-
mune manifestations. J. Exp. Med.
190, 1697–1710.
Martin, F., and Kearney, J. F. (2002).
Marginal-zone B cells. Nat. Rev.
Immunol. 2, 323–335.
Martin, F., Oliver, A. M., and Kear-
ney, J. F. (2001). Marginal zone and
B1 B cells unite in the early response
against T-independent blood-borne
particulate antigens. Immunity 14,
617–629.
Martinez-Gallo, M., Radigan, L., Alme-
jun, M. B., Martinez-Pomar, N.,
Matamoros, N., and Cunningham-
Rundles, C. (2013). TACI mutations
and impaired B-cell function in sub-
jects with CVID and healthy het-
erozygotes. J. Allergy Clin. Immunol.
131, 468–476.
Miller, D. J., and Hayes, C. E. (1991).
Phenotypic and genetic characteriza-
tion of a unique B lymphocyte deﬁ-
ciency in strain A/WySnJ mice. Eur. J.
Immunol. 21, 1123–1130.
Miller, J. P., Stadanlick, J. E., andCancro,
M. P. (2006). Space, selection, and
surveillance: setting boundaries with
BLyS. J. Immunol. 176, 6405–6410.
Mold, J. E., and McCune, J. M. (2011).
At the crossroads between tolerance
Frontiers in Immunology | B Cell Biology February 2013 | Volume 4 | Article 37 | 8
“ﬁmmu-04-00037” — 2013/2/22 — 15:35 — page 9 — #9
Sindhava et al. Homeostasis of innate/adaptive B cells
and aggression: revisiting the “lay-
ered immune system” hypothesis.
Chimerism 2, 35–41.
Montecino-Rodriguez, E., and Dor-
shkind, K. (2006). New perspectives
in B-1 B cell development and func-
tion. Trends Immunol. 27, 428–433.
Montecino-Rodriguez, E., and Dor-
shkind, K. (2011). Formation of
B-1 B cells from neonatal B-1 tran-
sitional cells exhibits NF-kappaB
redundancy. J. Immunol. 187, 5712–
5719.
Montecino-Rodriguez, E., and Dor-
shkind, K. (2012). B-1 B cell develop-
ment in the fetus and adult. Immunity
36, 13–21.
Montecino-Rodriguez, E., Leathers, H.,
and Dorshkind, K. (2006). Identiﬁca-
tion of a B-1 B cell-speciﬁed progen-
itor. Nat. Immunol. 7, 293–301.
Moore, P. A., Belvedere, O., Orr, A.,
Pieri, K., LaFleur, D. W., Feng, P.,
et al. (1999). BLyS: member of the
tumor necrosis factor family and B
lymphocyte stimulator. Science 285,
260–263.
Moreaux, J., Cremer, F. W., Reme,
T., Raab, M., Mahtouk, K., Kaukel,
P., et al. (2005). The level of TACI
gene expression in myeloma cells
is associated with a signature of
microenvironment dependence ver-
sus a plasmablastic signature. Blood
106, 1021–1030.
Mukhopadhyay, A., Ni, J., Zhai, Y., Yu,
G. L., and Aggarwal, B. B. (1999).
Identiﬁcation and characterization of
a novel cytokine, THANK, a TNF
homologue that activates apopto-
sis, nuclear factor-kappaB, and c-Jun
NH2-terminal kinase. J. Biol. Chem.
274, 15978–15981.
Nardelli, B., Belvedere, O., Roschke,
V., Moore, P. A., Olsen, H. S.,
Migone, T. S., et al. (2001). Synthesis
and release of B-lymphocyte stimu-
lator from myeloid cells. Blood 97,
198–204.
Ng, L. G., Ng, C. H., Woehl, B., Suther-
land, A. P., Huo, J., Xu, S., et al.
(2006). BAFF costimulation of Toll-
like receptor-activated B-1 cells. Eur.
J. Immunol. 36, 1837–1846.
O’Connor, B. P., Raman, V. S., Erick-
son, L. D., Cook, W. J., Weaver, L.
K., Ahonen, C., et al. (2004). BCMA
is essential for the survival of long-
lived bone marrow plasma cells. J.
Exp. Med. 199, 91–98.
Oropallo, M. A., Kiefer, K., Marshak-
Rothstein, A., and Cancro, M. P.
(2011). Beyond transitional selec-
tion: New roles for BLyS in periph-
eral tolerance. Drug Dev. Res. 72,
779–787.
Palanichamy, A., Barnard, J., Zheng, B.,
Owen, T., Quach, T., Wei, C., et al.
(2009). Novel human transitional B
cell populations revealed by B cell
depletion therapy. J. Immunol. 182,
5982–5993.
Pennell, C. A. (1995). Selection for
S107-V11 gene expression by peri-
toneal B cells in adult mice. J.
Immunol. 155, 1264–1275.
Pennell, C. A., Mercolino, T. J.,
Grdina, T. A., Arnold, L. W.,
Haughton, G., and Clarke, S. H.
(1989). Biased immunoglobulin vari-
able region gene expression by Ly-1 B
cells due to clonal selection. Eur. J.
Immunol. 19, 1289–1295.
Phan, T. G., Gardam, S., Basten, A.,
and Brink, R. (2005). Altered migra-
tion, recruitment, and somatic hyper-
mutation in the early response of
marginal zone B cells to T cell-
dependent antigen. J. Immunol. 174,
4567–4578.
Piatelli, M. J., Tanguay, D., Rothstein, T.
L., and Chiles, T. C. (2003). Cell cycle
control mechanisms in B-1 and B-2
lymphoid subsets. Immunol. Res. 27,
31–52.
Planelles, L., Carvalho-Pinto, C. E.,
Hardenberg, G., Smaniotto, S.,
Savino, W., Gomez-Caro, R., et al.
(2004). APRIL promotes B-1 cell-
associated neoplasm. Cancer Cell 6,
399–408.
Pradet-Balade, B., Medema, J. P., Lopez-
Fraga, M., Lozano, J. C., Kolfschoten,
G. M., Picard, A., et al. (2002). An
endogenous hybrid mRNA encodes
TWE-PRIL, a functional cell sur-
face TWEAK-APRIL fusion protein.
EMBO J. 21, 5711–5720.
Qin, X. F., Schwers, S.,Yu,W., Papavasil-
iou, F., Suh,H.,Nussenzweig,A., et al.
(1999). Secondary V(D)J recombi-
nation in B-1 cells. Nature 397,
355–359.
Rahman, Z. S., Rao, S. P., Kalled, S.
L., and Manser, T. (2003). Normal
induction but attenuated progression
of germinal center responses in BAFF
andBAFF-R signaling-deﬁcientmice.
J. Exp. Med. 198, 1157–1169.
Reijmers, R. M., Groen, R. W., Kuil, A.,
Weijer, K., Kimberley, F. C., Medema,
J. P., et al. (2011). Disruption of hep-
aran sulfate proteoglycan conforma-
tion perturbs B-cell maturation and
APRIL-mediatedplasma cell survival.
Blood 117, 6162–6171.
Sakurai, D.,Hase,H., Kanno,Y., Kojima,
H., Okumura, K., and Kobata, T.
(2007). TACI regulates IgA produc-
tion by APRIL in collaboration with
HSPG. Blood 109, 2961–2967.
Sasaki, Y., Casola, S., Kutok, J. L., Rajew-
sky, K., and Schmidt-Supprian, M.
(2004). TNF family member B cell-
activating factor (BAFF) receptor-
dependent and -independent roles
for BAFF in B cell physiology. J.
Immunol. 173, 2245–2252.
Scapini, P., Nardelli, B., Nadali, G.,
Calzetti, F., Pizzolo, G., Montecucco,
C., et al. (2003). G-CSF-stimulated
neutrophils are a prominent source
of functional BLyS. J. Exp. Med. 197,
297–302.
Schiemann, B., Gommerman, J. L.,
Vora, K., Cachero, T. G., Shulga-
Morskaya, S., Dobles, M., et al.
(2001). An essential role for BAFF
in the normal development of B cells
through a BCMA-independent path-
way. Science 293, 2111–2114.
Schneider, P., MacKay, F., Steiner, V.,
Hofmann, K., Bodmer, J. L., Holler,
N., et al. (1999). BAFF, a novel ligand
of the tumor necrosis factor family,
stimulates B cell growth. J. Exp. Med.
189, 1747–1756.
Schneider, P., Takatsuka, H., Wilson, A.,
Mackay, F., Tardivel, A., Lens, S., et al.
(2001). Maturation of marginal zone
and follicular B cells requires B cell
activating factor of the tumor necro-
sis factor family and is independent
of B cell maturation antigen. J. Exp.
Med. 194, 1691–1697.
Scholz, J. L., Crowley, J. E., Tomayko, M.
M., Steinel, N., O’Neill, P. J., Quinn,
W. J. III, et al. (2008). BLyS inhibi-
tion eliminates primary B cells but
leaves natural and acquired humoral
immunity intact. Proc. Natl. Acad.
Sci. U.S.A. 105, 15517–15522.
Scholz, J. L., Luning Prak, E. T., and
Cancro, M. P. (2011). Targeting the
BLyS family in autoimmunity: a tale
of mouse and man. Clin. Invest. 1,
951–967.
Seidl, K. J., MacKenzie, J. D., Wang,
D., Kantor, A. B., Kabat, E. A., and
Herzenberg, L. A. (1997). Frequent
occurrence of identical heavy and
light chain Ig rearrangements. Int.
Immunol. 9, 689–702.
Seidl, K. J., Wilshire, J. A., MacKenzie,
J. D., Kantor, A. B., and Herzenberg,
L. A. (1999). Predominant VH genes
expressed in innate antibodies are
associated with distinctive antigen-
binding sites. Proc. Natl. Acad. Sci.
U.S.A. 96, 2262–2267.
Shinkai, Y., Rathbun, G., Lam, K. P.,
Oltz, E. M., Stewart, V., Mendelsohn,
M., et al. (1992). RAG-2-deﬁcient
mice lack mature lymphocytes owing
to inability to initiate V(D)J rear-
rangement. Cell 68, 855–867.
Shulga-Morskaya, S.,Dobles,M.,Walsh,
M. E., Ng, L. G., MacKay, F., Rao, S.
P., et al. (2004). B cell-activating fac-
tor belonging to the TNF family acts
through separate receptors to support
B cell survival andT cell-independent
antibody formation. J. Immunol. 173,
2331–2341.
Song, H., and Cerny, J. (2003). Func-
tional heterogeneity of marginal zone
B cells revealed by their ability to gen-
erate both early antibody-forming
cells and germinal centerswithhyper-
mutation and memory in response to
a T-dependent antigen. J. Exp. Med.
198, 1923–1935.
Stadanlick, J. E., Kaileh, M., Karnell,
F. G., Scholz, J. L., Miller, J. P.,
Quinn, W. J. III, et al. (2008). Tonic
B cell antigen receptor signals supply
an NF-kappaB substrate for prosur-
vival BLyS signaling. Nat. Immunol.
9, 1379–1387.
Stein, J. V., Lopez-Fraga, M., Elus-
tondo, F. A., Carvalho-Pinto, C. E.,
Rodriguez, D., Gomez-Caro, R., et al.
(2002). APRIL modulates B and T
cell immunity. J. Clin. Invest. 109,
1587–1598.
Stohl, W. (2005). BlySfulness does not
equal blissfulness in systemic lupus
erythematosus: a therapeutic role for
BLyS antagonists. Curr. Dir. Autoim-
mun. 8, 289–304.
Stohl,W., Scholz, J. L., andCancro,M. P.
(2011). Targeting BLyS in rheumatic
disease: the sometimes-bumpy road
from bench to bedside. Curr. Opin.
Rheumatol. 23, 305–310.
Stohl, W., Xu, D., Kim, K. S., Koss,
M. N., Jorgensen, T. N., Deocharan,
B., et al. (2005). BAFF overexpression
and accelerated glomerular disease
in mice with an incomplete genetic
predisposition to systemic lupus ery-
thematosus. Arthritis Rheum. 52,
2080–2091.
Suzuki, K., Maruya, M., Kawamoto, S.,
and Fagarasan, S. (2010). Roles of B-
1 and B-2 cells in innate and acquired
IgA-mediated immunity. Immunol.
Rev. 237, 180–190.
Thompson, J. S., Bixler, S. A., Qian,
F., Vora, K., Scott, M. L., Cachero,
T. G., et al. (2001). BAFF-R, a newly
identiﬁed TNF receptor that speciﬁ-
cally interacts with BAFF. Science 293,
2108–2111.
Tomayko, M. M., Steinel, N. C., Ander-
son, S. M., and Shlomchik, M. J.
(2010). Cutting edge: hierarchy of
maturity of murine memory B cell
subsets. J. Immunol. 185, 7146–
7150.
Treml, J. F., Hao, Y., Stadanlick, J. E.,
and Cancro, M. P. (2009). The BLyS
family: toward a molecular under-
standing of B cell homeostasis. Cell
Biochem. Biophys. 53, 1–16.
Treml, L. S., Crowley, J. E., and Can-
cro, M. P. (2006). BLyS receptor
signatures resolve homeostatically
independent compartments among
naive and antigen-experienced
B cells. Semin. Immunol. 18,
297–304.
www.frontiersin.org February 2013 | Volume 4 | Article 37 | 9
“ﬁmmu-04-00037” — 2013/2/22 — 15:35 — page 10 — #10
Sindhava et al. Homeostasis of innate/adaptive B cells
Tumang, J. R., Hastings, W. D., Bai,
C., and Rothstein, T. L. (2004). Peri-
toneal and splenic B-1 cells are sepa-
rable by phenotypic, functional, and
transcriptomic characteristics. Eur. J.
Immunol. 34, 2158–2167.
Vale, A. M., Tanner, J. M., Schelonka,
R. L., Zhuang, Y., Zemlin, M., Gart-
land, G. L., et al. (2010). The peri-
toneal cavity B-2 antibody repertoire
appears to reﬂect many of the same
selective pressures that shape the B-
1a and B-1b repertoires. J. Immunol.
185, 6085–6095.
Varfolomeev, E., Kischkel, F., Mar-
tin, F., Seshasayee, D., Wang, H.,
Lawrence, D., et al. (2004). APRIL-
deﬁcient mice have normal immune
system development. Mol. Cell. Biol.
24, 997–1006.
Victora, G. D., and Nussenzweig, M. C.
(2012). Germinal centers. Annu. Rev.
Immunol. 30, 429–457.
von Bulow, G. U., van Deursen, J. M.,
and Bram, R. J. (2001). Regulation of
the T-independent humoral response
by TACI. Immunity 14, 573–582.
Vora, K. A., Wang, L. C., Rao, S. P., Liu,
Z. Y., Majeau, G. R., Cutler, A. H.,
et al. (2003). Cutting edge: germinal
centers formed in the absence of B
cell-activating factor belonging to the
TNF family exhibit impaired matu-
ration and function. J. Immunol. 171,
547–551.
Wallweber, H. J., Compaan, D. M.,
Starovasnik, M. A., and Hymowitz,
S. G. (2004). The crystal structure
of a proliferation-inducing ligand,
APRIL. J. Mol. Biol. 343, 283–290.
Warnatz, K., Salzer, U., Rizzi, M., Fis-
cher, B., Gutenberger, S., Bohm, J.,
et al. (2009). B-cell activating factor
receptor deﬁciency is associated with
an adult-onset antibody deﬁciency
syndrome in humans. Proc. Natl.
Acad. Sci. U.S.A. 106, 13945–13950.
Yan, M., Brady, J. R., Chan, B., Lee, W.
P., Hsu, B., Harless, S., et al. (2001).
Identiﬁcation of a novel receptor
for B lymphocyte stimulator that is
mutated in amouse strainwith severe
B cell deﬁciency. Curr. Biol. 11,
1547–1552.
Yang, M., Hase, H., Legarda-Addison,
D., Varughese, L., Seed, B., and Ting,
A. T. (2005). B cell maturation anti-
gen, the receptor for a proliferation-
inducing ligand and B cell-activating
factor of the TNF family, induces
antigen presentation in B cells. J.
Immunol. 175, 2814–2824.
Yoshimoto, M., Montecino-Rodriguez,
E., Ferkowicz, M. J., Porayette,
P., Shelley, W. C., Conway, S. J.,
et al. (2011). Embryonic day 9 yolk
sac and intra-embryonic hemogenic
endothelium independently generate
a B-1 and marginal zone progeni-
tor lacking B-2 potential. Proc. Natl.
Acad. Sci. U.S.A. 108, 1468–1473.
Yu, G., Boone, T., Delaney, J., Hawkins,
N., Kelley, M., Ramakrishnan, M.,
et al. (2000). APRIL and TALL-I and
receptors BCMA and TACI: system
for regulating humoral immunity.
Nat. Immunol. 1, 252–256.
Conflict of Interest Statement: The
authors declare that the research was
conducted in the absence of any
commercial or ﬁnancial relationships
that could be construed as a potential
conﬂict of interest.
Received: 31 October 2012; accepted:
31 January 2013; published online: 25
February 2013.
Citation: Sindhava VJ, Scholz JL and
Cancro MP (2013) Roles for BLyS family
members in meeting the distinct homeo-
static demands of innate and adaptive B
cells. Front. Immunol. 4:37. doi: 10.3389/
ﬁmmu.2013.00037
This article was submitted to Frontiers in
B Cell Biology, a specialty of Frontiers in
Immunology.
Copyright © 2013 Sindhava, Scholz and
Cancro. This is an open-access article dis-
tributed under the terms of the Creative
Commons Attribution License, which
permits use, distribution and reproduc-
tion in other forums, provided the origi-
nal authors and source are credited and
subject to any copyright notices concern-
ing any third-party graphics etc.
Frontiers in Immunology | B Cell Biology February 2013 | Volume 4 | Article 37 | 10
